GREGORY MASTERS, MD
Medical Oncology Physician · NEWARK, DE
Individual Active NPI 1508834680
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 439 | 96,285 | $11,422,945 | $3,556,369 | $2,831,294 |
| 2023 | 450 | 107,494 | $13,640,075 | $4,327,596 | $3,442,513 |
| 2022 | 487 | 111,060 | $11,654,671 | $4,069,782 | $3,241,228 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 14,200 | $53 | $43 |
| J0897 | Injection, denosumab, 1 mg | 7,860 | $26 | $21 |
| J9267 | Injection, paclitaxel, 1 mg | 7,156 | $0 | $0 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,488 | $0 | $0 |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 1,584 | $26 | $20 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 570 | $1 | $1 |
| J0640 | Injection, leucovorin calcium, per 50 mg | 544 | $5 | $4 |
| J9045 | Injection, carboplatin, 50 mg | 510 | $4 | $3 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 424 | $133 | $104 |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 404 | $132 | $99 |
| J9190 | Injection, fluorouracil, 500 mg | 350 | $3 | $2 |
| 96375 | Injection of additional new drug or substance into vein | 303 | $16 | $13 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | C10006866 | DE |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Delaware
- NPI 1942618962
- NPI 1770044778
- NPI 1841268927
- NPI 1518997147
- NPI 1962997668
- NPI 1295292183
- NPI 1104383041
- NPI 1366850265
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.